
Immune Cell Therapy Drugs - Global and China Top Players Market Share and Ranking 2025
Discover the latest insights into the booming Immune Cell Therapy Drugs Market. This report analyzes market size, growth trends (CAGR 30.20%), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for 2024-2031.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
• The global Immune Cell Therapy Drugs market was valued at US$ 4408 Million in 2024
• It is estimated to expand at a CAGR of 30.20% % from 2024 to 2031
• The global Immune Cell Therapy Drugs market is expected to reach the value of US$ 28330 Million by the end of 2031
Immune Cell Therapy Drugs Market Overview
Immune Cell Therapy Drugs refer to medications that are used in immune cell therapies to modulate and enhance the patient"s immune response against diseases like cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report studies and analyses global Immune Cell Therapy Drugs status and future trends, helping the client to determine the Immune Cell Therapy Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Immune Cell Therapy Drugs. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.
Immune Cell Therapy Drugs Market Key Takeaways
(1) Global Immune Cell Therapy Drugs market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Immune Cell Therapy Drugs sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Immune Cell Therapy Drugs sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Immune Cell Therapy Drugs key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Immune Cell Therapy Drugs key producing regions, capacity, production, and year-over-year growth
(6) Immune Cell Therapy Drugs industry chains, upstream, midstream, and downstream
Immune Cell Therapy Drugs Market: Key Players
The competitive landscape of the Immune Cell Therapy Drugs Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Immune Cell Therapy Drugs Market. Some of the major players operating in the Immune Cell Therapy Drugs Market are:
- Aquila BioMedical
- BPS Bioscience
- Celentyx
- Crown Bioscience
- DiscoverX Corporation
- Explicyte
- Genscript Biotech Corporation
- HD Biosciences
- Horizon Discovery Group
- ImmunXperts
- Molecular Imaging
- Promega Corporation,Personalis
- STC Biologics
Market IntelliX's study on the Immune Cell Therapy Drugs market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Immune Cell Therapy Drugs Market by Type [Analysis by Value from 2020 to 2031]:
- Monoclonal Antibodies
- Immunomodulator
- Other
Immune Cell Therapy Drugs Market by Application [Analysis by Value from 2020 to 2031]:
- Stomach Cancer
- lung Cancer
- Colorectal Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Other
Immune Cell Therapy Drugs Market by Region [Analysis by Value from 2020 to 2031]:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America (Brazil, Argentina and Colombia etc.)
- Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
Immune Cell Therapy Drugs Market Report Includes:
Chapter 1: To describe Immune Cell Therapy Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Immune Cell Therapy Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 3: China Immune Cell Therapy Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 4: Global key producing regions of Immune Cell Therapy Drugs , percent & CAGR, 2020 - 2031
Chapter 5: Immune Cell Therapy Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Immune Cell Therapy Drugs Definition
1.2 Global Immune Cell Therapy Drugs Market Size and Forecast
1.3 China Immune Cell Therapy Drugs Market Size and Forecast
1.4 Share of China Immune Cell Therapy Drugs Market with Respect to the Global Market
1.5 Immune Cell Therapy Drugs Market Size: China VS Global Growth Rate, 2020-2031
1.6 Immune Cell Therapy Drugs Market Dynamics
1.6.1 Immune Cell Therapy Drugs Market Drivers
1.6.2 Immune Cell Therapy Drugs Market Restraints
1.6.3 Immune Cell Therapy Drugs Industry Trends
1.6.4 Immune Cell Therapy Drugs Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Immune Cell Therapy Drugs, Global Market Share by Company, 2020-2025
2.2 Global Immune Cell Therapy Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Immune Cell Therapy Drugs Concentration Ratio
2.4 Global Immune Cell Therapy Drugs Mergers & Acquisitions, Expansion Plans
2.5 Global Immune Cell Therapy Drugs Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Immune Cell Therapy Drugs, China Market Share by Company, 2020-2025
3.2 China Immune Cell Therapy Drugs Immune Cell Therapy Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Immune Cell Therapy Drugs Industry Chain
4.2 Immune Cell Therapy Drugs Upstream Analysis
4.2.1 Immune Cell Therapy Drugs Core Raw Materials
4.2.2 Main Manufacturers of Immune Cell Therapy Drugs Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Immune Cell Therapy Drugs Production Mode
4.6 Immune Cell Therapy Drugs Procurement Model
4.7 Immune Cell Therapy Drugs Industry Sales Model and Sales Channels
4.7.1 Immune Cell Therapy Drugs Sales Model
4.7.2 Immune Cell Therapy Drugs Typical Distributors
5 Sights by Type
5.1 Immune Cell Therapy Drugs Classification
5.1.1 Monoclonal Antibodies
5.1.2 Immunomodulator
5.1.3 Other
5.2 by Type, Global Immune Cell Therapy Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031
6 Sights by Application
6.1 Immune Cell Therapy Drugs Segment by Application
6.1.1 Stomach Cancer
6.1.2 lung Cancer
6.1.3 Colorectal Cancer
6.1.4 Esophageal Cancer
6.1.5 Pancreatic Cancer
6.1.6 Other
6.2 by Application, Global Immune Cell Therapy Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031
7 Sales Sights by Region
7.1 By Region, Global Immune Cell Therapy Drugs Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Immune Cell Therapy Drugs Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Immune Cell Therapy Drugs Market Size Market Share
7.4 Europe
7.4.1 Europe Immune Cell Therapy Drugs Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Immune Cell Therapy Drugs Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Immune Cell Therapy Drugs Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Immune Cell Therapy Drugs Market Size Market Share
7.6 South America
7.6.1 South AmericaImmune Cell Therapy Drugs Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Immune Cell Therapy Drugs Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Immune Cell Therapy Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Immune Cell Therapy Drugs Market Size, 2020-2031
8.3.2 by Type, United States Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Immune Cell Therapy Drugs Market Size, 2020-2031
8.4.2 by Type, Europe Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Immune Cell Therapy Drugs Market Size, 2020-2031
8.5.2 by Type, China Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Immune Cell Therapy Drugs Market Size, 2020-2031
8.6.2 by Type, Japan Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Immune Cell Therapy Drugs Market Size, 2020-2031
8.7.2 by Type, South Korea Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Immune Cell Therapy Drugs Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Immune Cell Therapy Drugs Market Size, 2020-2031
8.9.2 by Type, India Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Immune Cell Therapy Drugs Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
9 Company Profile
9.1 Aquila BioMedical
9.1.1 Aquila BioMedical Company Information, Head Office, Market Area, and Industry Position
9.1.2 Aquila BioMedical Company Profile and Main Business
9.1.3 Aquila BioMedical Immune Cell Therapy Drugs Models, Specifications, and Application
9.1.4 Aquila BioMedical Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.1.5 Aquila BioMedical Recent Developments
9.2 BPS Bioscience
9.2.1 BPS Bioscience Company Information, Head Office, Market Area, and Industry Position
9.2.2 BPS Bioscience Company Profile and Main Business
9.2.3 BPS Bioscience Immune Cell Therapy Drugs Models, Specifications, and Application
9.2.4 BPS Bioscience Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.2.5 BPS Bioscience Recent Developments
9.3 Celentyx
9.3.1 Celentyx Company Information, Head Office, Market Area, and Industry Position
9.3.2 Celentyx Company Profile and Main Business
9.3.3 Celentyx Immune Cell Therapy Drugs Models, Specifications, and Application
9.3.4 Celentyx Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.3.5 Celentyx Recent Developments
9.4 Crown Bioscience
9.4.1 Crown Bioscience Company Information, Head Office, Market Area, and Industry Position
9.4.2 Crown Bioscience Company Profile and Main Business
9.4.3 Crown Bioscience Immune Cell Therapy Drugs Models, Specifications, and Application
9.4.4 Crown Bioscience Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.4.5 Crown Bioscience Recent Developments
9.5 DiscoverX Corporation
9.5.1 DiscoverX Corporation Company Information, Head Office, Market Area, and Industry Position
9.5.2 DiscoverX Corporation Company Profile and Main Business
9.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Models, Specifications, and Application
9.5.4 DiscoverX Corporation Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.5.5 DiscoverX Corporation Recent Developments
9.6 Explicyte
9.6.1 Explicyte Company Information, Head Office, Market Area, and Industry Position
9.6.2 Explicyte Company Profile and Main Business
9.6.3 Explicyte Immune Cell Therapy Drugs Models, Specifications, and Application
9.6.4 Explicyte Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.6.5 Explicyte Recent Developments
9.7 Genscript Biotech Corporation
9.7.1 Genscript Biotech Corporation Company Information, Head Office, Market Area, and Industry Position
9.7.2 Genscript Biotech Corporation Company Profile and Main Business
9.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Models, Specifications, and Application
9.7.4 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.7.5 Genscript Biotech Corporation Recent Developments
9.8 HD Biosciences
9.8.1 HD Biosciences Company Information, Head Office, Market Area, and Industry Position
9.8.2 HD Biosciences Company Profile and Main Business
9.8.3 HD Biosciences Immune Cell Therapy Drugs Models, Specifications, and Application
9.8.4 HD Biosciences Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.8.5 HD Biosciences Recent Developments
9.9 Horizon Discovery Group
9.9.1 Horizon Discovery Group Company Information, Head Office, Market Area, and Industry Position
9.9.2 Horizon Discovery Group Company Profile and Main Business
9.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Models, Specifications, and Application
9.9.4 Horizon Discovery Group Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.9.5 Horizon Discovery Group Recent Developments
9.10 ImmunXperts
9.10.1 ImmunXperts Company Information, Head Office, Market Area, and Industry Position
9.10.2 ImmunXperts Company Profile and Main Business
9.10.3 ImmunXperts Immune Cell Therapy Drugs Models, Specifications, and Application
9.10.4 ImmunXperts Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.10.5 ImmunXperts Recent Developments
9.11 Molecular Imaging
9.11.1 Molecular Imaging Company Information, Head Office, Market Area, and Industry Position
9.11.2 Molecular Imaging Company Profile and Main Business
9.11.3 Molecular Imaging Immune Cell Therapy Drugs Models, Specifications, and Application
9.11.4 Molecular Imaging Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.11.5 Molecular Imaging Recent Developments
9.12 Promega Corporation,Personalis
9.12.1 Promega Corporation,Personalis Company Information, Head Office, Market Area, and Industry Position
9.12.2 Promega Corporation,Personalis Company Profile and Main Business
9.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Models, Specifications, and Application
9.12.4 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.12.5 Promega Corporation,Personalis Recent Developments
9.13 STC Biologics
9.13.1 STC Biologics Company Information, Head Office, Market Area, and Industry Position
9.13.2 STC Biologics Company Profile and Main Business
9.13.3 STC Biologics Immune Cell Therapy Drugs Models, Specifications, and Application
9.13.4 STC Biologics Immune Cell Therapy Drugs Revenue and Gross Margin, 2020-2025
9.13.5 STC Biologics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Immune Cell Therapy Drugs Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Immune Cell Therapy Drugs Market Restraints
Table 3. Immune Cell Therapy Drugs Market Trends
Table 4. Immune Cell Therapy Drugs Industry Policy
Table 5. Global Immune Cell Therapy Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Immune Cell Therapy Drugs Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Immune Cell Therapy Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Immune Cell Therapy Drugs Mergers & Acquisitions, Expansion Plans
Table 9. Global Immune Cell Therapy Drugs Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Immune Cell Therapy Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 12. China Immune Cell Therapy Drugs Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Immune Cell Therapy Drugs Upstream (Raw Materials)
Table 14. Global Immune Cell Therapy Drugs Typical Customers
Table 15. Immune Cell Therapy Drugs Typical Distributors
Table 16. by Type, Global Immune Cell Therapy Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. by Application, Global Immune Cell Therapy Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Immune Cell Therapy Drugs Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 19. By Region, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Table 20. By Country, Global Immune Cell Therapy Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Table 22. By Country, Global Immune Cell Therapy Drugs Consumption Value Market Share, 2020-2031
Table 23. Aquila BioMedical Company Information, Head Office, Market Area, and Industry Position
Table 24. Aquila BioMedical Company Profile and Main Business
Table 25. Aquila BioMedical Immune Cell Therapy Drugs Models, Specifications, and Application
Table 26. Aquila BioMedical Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 27. Aquila BioMedical Recent Developments
Table 28. BPS Bioscience Company Information, Head Office, Market Area, and Industry Position
Table 29. BPS Bioscience Company Profile and Main Business
Table 30. BPS Bioscience Immune Cell Therapy Drugs Models, Specifications, and Application
Table 31. BPS Bioscience Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 32. BPS Bioscience Recent Developments
Table 33. Celentyx Company Information, Head Office, Market Area, and Industry Position
Table 34. Celentyx Company Profile and Main Business
Table 35. Celentyx Immune Cell Therapy Drugs Models, Specifications, and Application
Table 36. Celentyx Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 37. Celentyx Recent Developments
Table 38. Crown Bioscience Company Information, Head Office, Market Area, and Industry Position
Table 39. Crown Bioscience Company Profile and Main Business
Table 40. Crown Bioscience Immune Cell Therapy Drugs Models, Specifications, and Application
Table 41. Crown Bioscience Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 42. Crown Bioscience Recent Developments
Table 43. DiscoverX Corporation Company Information, Head Office, Market Area, and Industry Position
Table 44. DiscoverX Corporation Company Profile and Main Business
Table 45. DiscoverX Corporation Immune Cell Therapy Drugs Models, Specifications, and Application
Table 46. DiscoverX Corporation Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 47. DiscoverX Corporation Recent Developments
Table 48. Explicyte Company Information, Head Office, Market Area, and Industry Position
Table 49. Explicyte Company Profile and Main Business
Table 50. Explicyte Immune Cell Therapy Drugs Models, Specifications, and Application
Table 51. Explicyte Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 52. Explicyte Recent Developments
Table 53. Genscript Biotech Corporation Company Information, Head Office, Market Area, and Industry Position
Table 54. Genscript Biotech Corporation Company Profile and Main Business
Table 55. Genscript Biotech Corporation Immune Cell Therapy Drugs Models, Specifications, and Application
Table 56. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 57. Genscript Biotech Corporation Recent Developments
Table 58. HD Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 59. HD Biosciences Company Profile and Main Business
Table 60. HD Biosciences Immune Cell Therapy Drugs Models, Specifications, and Application
Table 61. HD Biosciences Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 62. HD Biosciences Recent Developments
Table 63. Horizon Discovery Group Company Information, Head Office, Market Area, and Industry Position
Table 64. Horizon Discovery Group Company Profile and Main Business
Table 65. Horizon Discovery Group Immune Cell Therapy Drugs Models, Specifications, and Application
Table 66. Horizon Discovery Group Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 67. Horizon Discovery Group Recent Developments
Table 68. ImmunXperts Company Information, Head Office, Market Area, and Industry Position
Table 69. ImmunXperts Company Profile and Main Business
Table 70. ImmunXperts Immune Cell Therapy Drugs Models, Specifications, and Application
Table 71. ImmunXperts Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 72. ImmunXperts Recent Developments
Table 73. Molecular Imaging Company Information, Head Office, Market Area, and Industry Position
Table 74. Molecular Imaging Company Profile and Main Business
Table 75. Molecular Imaging Immune Cell Therapy Drugs Models, Specifications, and Application
Table 76. Molecular Imaging Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 77. Molecular Imaging Recent Developments
Table 78. Promega Corporation,Personalis Company Information, Head Office, Market Area, and Industry Position
Table 79. Promega Corporation,Personalis Company Profile and Main Business
Table 80. Promega Corporation,Personalis Immune Cell Therapy Drugs Models, Specifications, and Application
Table 81. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 82. Promega Corporation,Personalis Recent Developments
Table 83. STC Biologics Company Information, Head Office, Market Area, and Industry Position
Table 84. STC Biologics Company Profile and Main Business
Table 85. STC Biologics Immune Cell Therapy Drugs Models, Specifications, and Application
Table 86. STC Biologics Immune Cell Therapy Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 87. STC Biologics Recent Developments
List of Figures
Figure 1. Immune Cell Therapy Drugs Picture
Figure 2. Global Immune Cell Therapy Drugs Consumption Value, (US$ million) & (2020-2031)
Figure 3. China Immune Cell Therapy Drugs Consumption Value, (US$ million) & (2020-2031)
Figure 4. By Consumption Value, China Immune Cell Therapy Drugs Market Share of Global, 2020-2031
Figure 5. Global Immune Cell Therapy Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 6. China Immune Cell Therapy Drugs Key Participants, Market Share, 2024
Figure 7. Immune Cell Therapy Drugs Industry Chain
Figure 8. Immune Cell Therapy Drugs Procurement Model
Figure 9. Immune Cell Therapy Drugs Sales Model
Figure 10. Immune Cell Therapy Drugs Sales Channels, Direct Sales, and Distribution
Figure 11. Monoclonal Antibodies
Figure 12. Immunomodulator
Figure 13. Other
Figure 14. by Type, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 15. by Type, Global Immune Cell Therapy Drugs Consumption Value Market Share, 2020-2031
Figure 16. Stomach Cancer
Figure 17. lung Cancer
Figure 18. Colorectal Cancer
Figure 19. Esophageal Cancer
Figure 20. Pancreatic Cancer
Figure 21. Other
Figure 22. by Application, Global Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 23. by Application, Global Immune Cell Therapy Drugs Revenue Market Share, 2020-2031
Figure 24. By Region, Global Immune Cell Therapy Drugs Consumption Value Market Share, 2020-2031
Figure 25. North America Immune Cell Therapy Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 26. By Country, North America Immune Cell Therapy Drugs Consumption Value Market Share, 2024
Figure 27. Europe Immune Cell Therapy Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 28. By Country, Europe Immune Cell Therapy Drugs Consumption Value Market Share, 2024
Figure 29. Asia Pacific Immune Cell Therapy Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 30. By Country/Region, Asia Pacific Immune Cell Therapy Drugs Consumption Value Market Share, 2024
Figure 31. South America Immune Cell Therapy Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 32. By Country, South America Immune Cell Therapy Drugs Consumption Value Market Share, 2024
Figure 33. Middle East & Africa Immune Cell Therapy Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 34. United States Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 35. by Type, United States Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 36. by Application, United States Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 37. Europe Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 38. by Type, Europe Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 39. by Application, Europe Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 40. China Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 41. by Type, China Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 42. by Application, China Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 43. Japan Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 44. by Type, Japan Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 45. by Application, Japan Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 46. South Korea Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 47. by Type, South Korea Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 48. by Application, South Korea Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 49. Southeast Asia Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 50. by Type, Southeast Asia Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 51. by Application, Southeast Asia Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 52. India Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 53. by Type, India Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 54. by Application, India Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 55. Middle East & Africa Immune Cell Therapy Drugs Consumption Value, 2020-2031, US$ Million
Figure 56. by Type, Middle East & Africa Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 57. by Application, Middle East & Africa Immune Cell Therapy Drugs Consumption Value Market Share, 2024 VS 2031
Figure 58. Research Methodology
Figure 59. Breakdown of Primary Interviews
Figure 60. Bottom-up Approaches
Figure 61. Top-down Approaches
Research Methodology:
Immune Cell Therapy Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|